Literature DB >> 3036059

Molecular biology and immunology of cytomegalovirus.

P D Griffiths, J E Grundy.   

Abstract

The application of modern biochemical techniques has led to a rapid improvement in our knowledge of the molecular biology of CMV. Several coding regions of the DNA genome have been identified with certainty and major virus-coded proteins have been given provisional names. The cascade expression of the CMV genome has been shown to be controlled by mechanisms similar to those found in other herpes viruses, together with novel post-transcriptional controls which remain to be defined. The control of CMV replication by the host involves both non-specific and specific defence mechanisms. The induction of natural killer cells and interferon early after CMV infection appears to be the most important aspects of the non-specific host defence against the virus. The cell-mediated immune response, in particular the generation of Tc cells against CMV early antigens, is probably the most important facet of the specific immune defence against CMV. When intact these defence mechanisms appear to be efficient in restricting viral replication; however, when such immunity is compromised, the balance rapidly swings in favour of the virus. As our understanding of the interaction between the host and the virus increases, it may be possible to redress the balance in such cases in favour of the host.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3036059      PMCID: PMC1147564          DOI: 10.1042/bj2410313

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  176 in total

1.  Membrane glycoproteins and antigens induced by human cytomegalovirus.

Authors:  M F Stinski; E S Mocarski; D R Thomsen; M L Urbanowski
Journal:  J Gen Virol       Date:  1979-04       Impact factor: 3.891

2.  Immediate early antigens in human cytomegalovirus infected cells.

Authors:  S Michelson-Fiske; F Horodniceanu; J C Guillon
Journal:  Nature       Date:  1977-12-15       Impact factor: 49.962

3.  Lysis of human cytomegalovirus infected fibroblasts by natural killer cells: demonstration of an interferon-independent component requiring expression of early viral proteins and characterization of effector cells.

Authors:  L K Borysiewicz; B Rodgers; S Morris; S Graham; J G Sissons
Journal:  J Immunol       Date:  1985-04       Impact factor: 5.422

4.  Cytomegalovirus-induced immune suppression. I. Humoral immunity.

Authors:  R J Howard; J S Najarian
Journal:  Clin Exp Immunol       Date:  1974-09       Impact factor: 4.330

5.  Post-transcriptional control of human cytomegalovirus gene expression.

Authors:  J M DeMarchi
Journal:  Virology       Date:  1983-01-30       Impact factor: 3.616

6.  Immunological basis for latency, recurrences and putative oncogenicity of herpes simplex virus.

Authors:  T Lehner; J M Wilton; E J Shillitoe
Journal:  Lancet       Date:  1975-07-12       Impact factor: 79.321

7.  Polypeptide-specific antibody response to human cytomegalovirus after infection in bone marrow transplant recipients.

Authors:  J A Zaia; S J Forman; Y P Ting; E Vanderwal-Urbina; K G Blume
Journal:  J Infect Dis       Date:  1986-04       Impact factor: 5.226

8.  Isolation of human cytomegalovirus intranuclear capsids, characterization of their protein constituents, and demonstration that the B-capsid assembly protein is also abundant in noninfectious enveloped particles.

Authors:  A Irmiere; W Gibson
Journal:  J Virol       Date:  1985-10       Impact factor: 5.103

9.  Effects of interferon-alpha on cytomegalovirus reactivation syndromes in renal-transplant recipients.

Authors:  M S Hirsch; R T Schooley; A B Cosimi; P S Russell; F L Delmonico; N E Tolkoff-Rubin; J T Herrin; K Cantell; M L Farrell; T R Rota; R H Rubin
Journal:  N Engl J Med       Date:  1983-06-23       Impact factor: 91.245

10.  Physical mapping of human cytomegalovirus genes: identification of DNA sequences coding for a virion phosphoprotein of 71 kDa and a viral 65-kDa polypeptide.

Authors:  B Nowak; A Gmeiner; P Sarnow; A J Levine; B Fleckenstein
Journal:  Virology       Date:  1984-04-15       Impact factor: 3.616

View more
  30 in total

1.  Human cytomegalovirus IE2 86-kilodalton protein binds p53 but does not abrogate G1 checkpoint function.

Authors:  L R Bonin; J K McDougall
Journal:  J Virol       Date:  1997-08       Impact factor: 5.103

2.  The roles of tumour necrosis factor-alpha, interleukin-1 and interleukin-12 in murine cytomegalovirus infection.

Authors:  S T Yerkovich; S D Olver; J C Lenzo; C D Peacock; P Price
Journal:  Immunology       Date:  1997-05       Impact factor: 7.397

3.  The intracellular localization of human cytomegalovirus DNA in peripheral blood leukocytes during active infections by high-resolution fluorescence in situ hybridization.

Authors:  H Hackstein; H Kirchner; G Jahn; G Bein
Journal:  Arch Virol       Date:  1996       Impact factor: 2.574

4.  Up-regulation of LFA-3 and ICAM-1 on the surface of fibroblasts infected with cytomegalovirus.

Authors:  J E Grundy; K L Downes
Journal:  Immunology       Date:  1993-03       Impact factor: 7.397

5.  Detection of cytomegalovirus antigens and DNA in tissues fixed in formaldehyde.

Authors:  N M Jiwa; A K Raap; F M van de Rijke; A Mulder; J J Weening; F E Zwaan; T H The; M van der Ploeg
Journal:  J Clin Pathol       Date:  1989-07       Impact factor: 3.411

6.  A comparative study of congenital and postnatally acquired human cytomegalovirus infection in infants: lack of expression of viral immediate early protein in congenital cases.

Authors:  A Maeda; T Sata; Y Sato; T Kurata
Journal:  Virchows Arch       Date:  1994       Impact factor: 4.064

7.  Characterization of a human cytomegalovirus 1.6-kilobase late mRNA and identification of its putative protein product.

Authors:  R S Lahijani; E W Otteson; J D Adlish; S C St Jeor
Journal:  J Virol       Date:  1991-01       Impact factor: 5.103

8.  CD13 (human aminopeptidase N) mediates human cytomegalovirus infection.

Authors:  C Söderberg; T D Giugni; J A Zaia; S Larsson; J M Wahlberg; E Möller
Journal:  J Virol       Date:  1993-11       Impact factor: 5.103

9.  Calnexin acts as a molecular chaperone during the folding of glycoprotein B of human cytomegalovirus.

Authors:  Y Yamashita; K Shimokata; S Mizuno; T Daikoku; T Tsurumi; Y Nishiyama
Journal:  J Virol       Date:  1996-04       Impact factor: 5.103

10.  Double fluorescence analysis of human cytomegalovirus (HCMV) infected human fibroblast cultures by flow cytometry: increase of class I MHC expression on uninfected cells and decrease on infected cells.

Authors:  M Steinmassl; K Hamprecht
Journal:  Arch Virol       Date:  1994       Impact factor: 2.574

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.